These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8938104)

  • 21. [X-linked agammaglobulinemia (XLA) associated with agranulocytosis--case report].
    Irga N; Wierzba J; Brozek J; Ochman K; Kanegane H; Miyawaki T; Neuman-Łaniec M
    Wiad Lek; 2003; 56(7-8):378-80. PubMed ID: 14969169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
    Hagemann TL; Chen Y; Rosen FS; Kwan SP
    Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection.
    Futatani T; Miyawaki T; Tsukada S; Hashimoto S; Kunikata T; Arai S; Kurimoto M; Niida Y; Matsuoka H; Sakiyama Y; Iwata T; Tsuchiya S; Tatsuzawa O; Yoshizaki K; Kishimoto T
    Blood; 1998 Jan; 91(2):595-602. PubMed ID: 9427714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
    Kanegane H; Futatani T; Wang Y; Nomura K; Shinozaki K; Matsukura H; Kubota T; Tsukada S; Miyawaki T
    J Allergy Clin Immunol; 2001 Dec; 108(6):1012-20. PubMed ID: 11742281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.
    Pérez de Diego R; López-Granados E; Pozo M; Rodríguez C; Sabina P; Ferreira A; Fontan G; García-Rodríguez MC; Alemany S
    J Allergy Clin Immunol; 2006 Jun; 117(6):1462-9. PubMed ID: 16751014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
    Vihinen M; Brandau O; Brandén LJ; Kwan SP; Lappalainen I; Lester T; Noordzij JG; Ochs HD; Ollila J; Pienaar SM; Riikonen P; Saha BK; Smith CI
    Nucleic Acids Res; 1998 Jan; 26(1):242-7. PubMed ID: 9399844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
    de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
    Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB; Lester T; Levinsky RJ; Kinnon C
    Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-linked agammaglobulinemia. A clinical and molecular analysis.
    Ochs HD; Smith CI
    Medicine (Baltimore); 1996 Nov; 75(6):287-99. PubMed ID: 8982147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis for X-linked agammaglobulinemia (XLA): mutations at interacting Btk residues R562, W563, and A582.
    Maniar HS; Vihinen M; Webster AD; Nilsson L; Smith CI
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S198-202. PubMed ID: 7554468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
    Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
    Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
    Mattsson PT; Vihinen M; Smith CI
    Bioessays; 1996 Oct; 18(10):825-34. PubMed ID: 8885720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new mutation that predicted a drastic alteration of the BTK protein function.
    Debost-Legrand A; Legrand G; Moulillot G; Francannet C; Bocly B; Theodoroub I; Paillard C
    Gene; 2013 Sep; 527(1):426-8. PubMed ID: 23774691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia.
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 1997 Jan; 2():d27-42. PubMed ID: 9159207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
    Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW
    Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India.
    Rawat A; Jindal AK; Suri D; Vignesh P; Gupta A; Saikia B; Minz RW; Banday AZ; Tyagi R; Arora K; Joshi V; Mondal S; Shandilya JK; Sharma M; Desai M; Taur P; Pandrowala A; Gowri V; Sawant-Desai S; Gupta M; Dalvi AD; Madkaikar M; Aggarwal A; Raj R; Uppuluri R; Bhattad S; Jayaram A; Lashkari HP; Rajasekhar L; Munirathnam D; Kalra M; Shukla A; Saka R; Sharma R; Garg R; Imai K; Nonoyama S; Ohara O; Lee PP; Chan KW; Lau YL; Singh S
    Front Immunol; 2020; 11():612323. PubMed ID: 33584693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twin carriers of X-linked agammaglobulinemia (XLA) due to germline mutation in the Btk gene.
    Curtis SK; Hebert MD; Saha BK
    Am J Med Genet; 2000 Jan; 90(3):229-32. PubMed ID: 10678660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
    Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
    Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations.
    Aadam Z; Kechout N; Barakat A; Chan KW; Ben-Ali M; Ben-Mustapha I; Zidi F; Ailal F; Attal N; Doudou F; Abbadi MC; Kaddache C; Smati L; Touri N; Chemli J; Gargah T; Brini I; Bakhchane A; Charoute H; Jeddane L; El Atiqi S; El Hafidi N; Hida M; Saile R; Alj HS; Boukari R; Bejaoui M; Najib J; Barbouche MR; Lau YL; Mellouli F; Bousfiha AA
    J Clin Immunol; 2016 Apr; 36(3):187-94. PubMed ID: 26931785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of BTK mutations in male Algerian patterns with agammaglobulinemia and severe B cell lymphopenia.
    Boushaki S; Tahiat A; Meddour Y; Chan KW; Chaib S; Benhalla N; Smati L; Bensenouci A; Lau YL; Magdinier F; Djidjik R
    Clin Immunol; 2015 Dec; 161(2):286-90. PubMed ID: 26387629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.